Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial
1. 系统已在2026-10-05 15:56:25对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s1474-4422(26)00215-2
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1474442226002152
其他信息:
出版社: Elsevier BV
作者: Hubert H Fernandez; Perminder Bhatia; Leslie Cloud; Urban M Fietzek; Michele Matarazzo; Eric Molho; Elizabeth Peckham; Arjun Tarakad; Cari Combs; Matthew Leoni; Ih Chang; Stacey Tringali; Joey Boiser; Raymond Sanchez; Cindy Zadikoff

